Emma Aneheim Selected Research

Astatine-211

1/2021	Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer.
11/2019	Towards elucidating the radiochemistry of astatine - Behavior in chloroform.
1/2019	Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior.
3/2016	Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates.
7/2015	Automated astatination of biomolecules--a stepping stone towards multicenter clinical trials.
2/2015	Shelf-life of ɛ-lysyl-3-(trimethylstannyl)benzamide immunoconjugates, precursors for 211At labeling of antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emma Aneheim Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 01/2015
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2015
1	Ascites 12/2017
1	Body Weight (Weight, Body) 12/2017

Drug/Important Bio-Agent (IBA)

6	Astatine-211IBA 01/2021 - 02/2015
2	AntibodiesIBA 01/2021 - 03/2016
2	Monoclonal AntibodiesIBA 12/2017 - 03/2016
2	AstatineIBA 03/2016 - 07/2015
1	farletuzumabIBA 01/2021
1	211At-labeled monoclonal antibody MX35IBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 03/2016
1	TinIBA 03/2016
1	Radioisotopes (Radionuclides)IBA 02/2015
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2015
1	EpitopesIBA 01/2015

Therapy/Procedure

6	Therapeutics 11/2019 - 02/2015
2	Radioimmunotherapy 12/2017 - 01/2015
1	Intravenous Injections 01/2021
1	Aftercare (After-Treatment) 12/2017